Securities and Exchange Board of India (SEBI) has issued a notice to Fortis Healthcare Limited in the case related to diversion of funds by the company’s former promoters.
“The management and Board of the Company that was newly constituted after NTK Ventures Pte Ltd (a wholly owned subsidiary of IHH Healthcare Berhad) became promoters of the Company, are evaluating the notice received by Escorts Heart Institute and Research Center Limited (a subsidiary of Fortis), in consultation with its legal advisors,” Fortis Healthcare said in stock exchange filings.
In 2018, the market regulator had asked Fortis Healthcare to take all necessary steps to recover ₹403 crore along with due interest from Malvinder Singh, Shivinder Singh and other entities including Religare Finvest Limited. SEBI has said that money should be recovered within three months.
The funds were reported on the balance sheet of Fortis Healthcare Ltd as cash and cash equivalents, but the money was routed and placed under the control of the Singhs at the time. Fortis’s auditor, Deloitte Haskins & Sells LLP, refused to sign off on the company’s second-quarter results until the funds were accounted for or returned, the people said, asking not to be identified as the information is private.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.